The first CRISPR medicine ever approved
In December 2023 regulators approved Casgevy — the world's first CRISPR gene-editing therapy. It works by switching off BCL11A in blood stem cells, reawakening the fetal hemoglobin we all make before birth, to treat sickle cell disease.
A symbol of a scientific miracle — and of resilience rewritten letter by letter.
GIFT BCL11A